Response to Article “Are There Differences in Gut Microbiome in Patients with Type 2 Diabetes Treated by Metformin or Metformin and Insulin?” [Letter]

"Response to Article “Are There Differences in Gut Microbiome in Patients with Type 2 Diabetes Treated by Metformin or Metformin and Insulin?” [Letter]." Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, , pp. 3889–3890

View responses to this article:

Response to Comment to the Article “Are There Differences in Gut Microbiome in Patients with Type 2 Diabetes Treated by Metformin or Metformin and Insulin?” [Response To Letter]

Acknowledgments

Full acknowledgements are conveyed to all supports given to all authors of the study commented in this letter during the study period. The authors also would like to appreciate Dr. Sunarno, the Head of Center for Biomedical Research in National Research and Innovation Agency (BRIN) for his continuous support during the letter manuscript preparation.

Author Contributions

NSDP went through the cited publications and analyzed the reported data. NSDP designed and conceived the critical design of the letter. NSDP wrote the original letter draft. CSWL and MSM recommended required corrections. NSDP, CSWL and MSM did necessary revision for improvement of the manuscript accordingly.

Disclosure

The authors report no conflicts of interest in this communication.